Australia markets closed

Lumos Pharma, Inc. (LUMO)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
7.50-0.11 (-1.47%)
At close: 12:59PM EST
7.45 -0.04 (-0.52%)
After hours: 01:06PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
50
168
936
12,474
28,711
Operating expenses
Research development
15,348
9,206
22,205
45,694
69,866
Selling general and administrative
16,534
17,265
23,865
29,218
31,726
Total operating expenses
31,882
26,471
46,070
74,912
101,592
Operating income or loss
-31,832
-26,303
-45,134
-62,438
-72,881
Interest expense
98
-
50
52
119
Total other income/expenses net
4
6,467
-19
-102
-126
Income before tax
-31,856
-19,636
-42,977
-60,563
-72,510
Income tax expense
-4,652
-13,973
12
-6,968
-559
Income from continuing operations
-27,204
-5,663
-42,989
-53,595
-71,951
Net income
-27,204
-5,663
-42,989
-53,595
-71,951
Net income available to common shareholders
-27,204
-6,314
-42,989
-53,595
-71,951
Basic EPS
-
-0.93
-10.35
-12.96
-20.70
Diluted EPS
-
-0.93
-10.35
-12.96
-20.70
Basic average shares
-
6,778
4,144
4,132
3,478
Diluted average shares
-
6,778
4,144
4,132
3,478
EBITDA
-
-25,719
-41,833
-59,366
-70,984